Solvay (SOLB) Aperçu de l'action
Solvay SA fournit des produits chimiques de base et de performance dans le monde entier. Plus de détails
| Score flocon de neige | |
|---|---|
| Évaluation | 5/6 |
| Croissance future | 4/6 |
| Performances passées | 0/6 |
| Santé financière | 3/6 |
| Dividendes | 3/6 |
SOLB Community Fair Values
Create NarrativeSee what 46 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Solvay SA Concurrents
Historique des prix et performances
| Historique des cours de bourse | |
|---|---|
| Prix actuel de l'action | €26.98 |
| Plus haut sur 52 semaines | €30.56 |
| Plus bas sur 52 semaines | €23.54 |
| Bêta | 0.25 |
| Variation sur 1 mois | 3.61% |
| Variation sur 3 mois | 1.50% |
| Variation sur 1 an | -8.17% |
| Variation sur 3 ans | -73.29% |
| Variation sur 5 ans | -75.18% |
| Évolution depuis l'introduction en bourse | -2.83% |
Nouvelles et mises à jour récentes
Article d’analyse • Jun 17
Solvay (ENXTBR:SOLB) Stock Could Be 8.8% Overvalued After European Patent Win
The European Patent Office has upheld Solvay (ENXTBR:SOLB)’s key European patent covering its soda ash purge stream recycling process after a challenge from WE Soda Ltd, putting the company’s intellectual property position firmly in focus for investors. See our latest analysis for Solvay. Solvay’s recent patent win comes at a time when the stock’s 7-day share price return of 5.98% and 30-day share price return of 4.12% sit against a 1-year total shareholder return that is down 3.84%, while...
Mise à jour du récit • Jun 11
SOLB: Rare Earth Supply Plans And Mixed Ratings Will Shape Fair Value Outlook
Narrative Update The analyst price target for Solvay is now set at €25.10. This move is supported by recent Street research, where analysts highlight the company’s rare earth capabilities and adjust targets in a €26 to €30 range, while fine tuning assumptions around discount rates, modest revenue declines, profit margins and future P/E expectations.Mise à jour du récit • May 28
SOLB: Mixed Ratings And Higher P/E Assumptions Will Shape Fair Value Outlook
Solvay's analyst price target has been trimmed by about €0.40 to reflect slightly lower fair value and profit margin assumptions, even as analysts factor in a higher future P/E multiple based on recent research updates. Analyst Commentary The latest round of research on Solvay points to a mixed view, with some analysts trimming price targets while others see room for the stock to trade at higher levels relative to earnings.Recent updates
Article d’analyse • Jun 17
Solvay (ENXTBR:SOLB) Stock Could Be 8.8% Overvalued After European Patent Win
The European Patent Office has upheld Solvay (ENXTBR:SOLB)’s key European patent covering its soda ash purge stream recycling process after a challenge from WE Soda Ltd, putting the company’s intellectual property position firmly in focus for investors. See our latest analysis for Solvay. Solvay’s recent patent win comes at a time when the stock’s 7-day share price return of 5.98% and 30-day share price return of 4.12% sit against a 1-year total shareholder return that is down 3.84%, while...Mise à jour du récit • Jun 11
SOLB: Rare Earth Supply Plans And Mixed Ratings Will Shape Fair Value Outlook
Narrative Update The analyst price target for Solvay is now set at €25.10. This move is supported by recent Street research, where analysts highlight the company’s rare earth capabilities and adjust targets in a €26 to €30 range, while fine tuning assumptions around discount rates, modest revenue declines, profit margins and future P/E expectations.Mise à jour du récit • May 28
SOLB: Mixed Ratings And Higher P/E Assumptions Will Shape Fair Value Outlook
Solvay's analyst price target has been trimmed by about €0.40 to reflect slightly lower fair value and profit margin assumptions, even as analysts factor in a higher future P/E multiple based on recent research updates. Analyst Commentary The latest round of research on Solvay points to a mixed view, with some analysts trimming price targets while others see room for the stock to trade at higher levels relative to earnings.Mise à jour du récit • Apr 19
SOLB: Mixed Ratings And Slightly Lower Assumptions Will Shape Fair Value Outlook
Solvay's analyst price target has edged down by about €0.13 as analysts adjust their fair value and P/E assumptions, reflecting recent target moves and downgrades from several banks while still incorporating some upward revisions from others. Analyst Commentary Recent research updates show a split view on Solvay, with some analysts lifting price targets while several others cut targets or downgraded their stance.Mise à jour du récit • Apr 02
SOLB: Trimmed Expectations And Mixed Ratings Will Still Support Fair Value
Solvay's analyst price target has been trimmed by about €0.25, as analysts factor in softer revenue expectations, slightly higher margin assumptions and a lower future P/E multiple. Analyst Commentary Recent Street research on Solvay points to a cautious stance, with several firms trimming price targets or downgrading ratings while a few still see upside at specific levels.Mise à jour du récit • Mar 19
SOLB: Rare Earth Role Will Offset Execution Risks And Support Fair Value
Analysts have nudged Solvay's fair value estimate slightly lower to about €25.72 per share. This reflects a mix of reduced profit margin assumptions, a modestly lower discount rate, and updated external price targets that now cluster in the €22 to €28 range.Mise à jour du récit • Mar 04
SOLB: Rare Earth Supply Role Will Temper Softer Outlook And Downgrades
Narrative Update on Solvay Our updated analyst price target for Solvay edges down slightly to €25.78 from €25.88. This reflects a modest recalibration of expected growth and margins, even as recent Street research has shifted targets in a tight €22 to €28 range with several downgrades and cautious P/E assumptions from analysts.Mise à jour du récit • Feb 18
SOLB: Rare Earth Supply Role Will Offset Softer Outlook And Downgrades
Analysts have reduced their price target on Solvay to about €25.88 from roughly €26.44, reflecting a series of recent downgrades and slightly softer assumptions for revenue, margins and fair value multiples. Analyst Commentary Bullish Takeaways Bullish analysts still see upside to the current share price, with some targets such as €28 and €27 implying room for rerating if execution on cost discipline and portfolio focus holds up.Mise à jour du récit • Feb 03
SOLB: Rare Earth Partnerships Will Counter Softer Outlook And Cautious Ratings
Analysts have trimmed their price targets on Solvay, with our fair value estimate moving from €27.19 to €26.44 as they factor in slightly softer revenue expectations, a higher discount rate, and lower assumed future P/E multiples, partly offset by firmer profit margin assumptions. Analyst Commentary Recent Street research on Solvay has leaned more cautious, with several firms lowering price targets and moving to more neutral or negative ratings as they reassess the risk and reward profile.Mise à jour du récit • Jan 19
SOLB: Rare Earth Agreements Will Offset Softer Outlook At A Fair Price
Analysts have nudged their Solvay price target slightly lower to about €27.19 from about €27.27, reflecting updated views on slower revenue trends, a higher discount rate, better profit margins, and a lower future P/E assumption, alongside recent target cuts and rating changes from several research houses. Analyst Commentary Recent research opinions around Solvay cluster around cautious updates to price targets and ratings, with most commentary focusing on how current execution and growth expectations line up against existing valuations.Mise à jour du récit • Jan 05
SOLB: Rare Earth Agreements Will Steady Execution Risks At A Fair Price
Analysts have trimmed their price target on Solvay to about €23.50, a modest reset that reflects slightly lower profit margin expectations while keeping fair value and P/E assumptions broadly in line with prior views. Analyst Commentary Recent research points to a slightly lower fair value marker for Solvay at about €23.50, which still sits close to prior assumptions on P/E and overall valuation.Mise à jour du récit • Dec 14
SOLB: Rare Earth Agreements Will Offset Softer Outlook And Heightened Execution Risks
Analysts trimmed their fair value estimate for Solvay by about EUR 0.50 per share, reflecting slightly higher perceived risk and softer long term growth expectations, in line with a series of recent price target cuts across the Street. Analyst Commentary Recent Street updates reflect a cautious stance on Solvay, with a series of modest price target reductions signaling tempered expectations for both earnings growth and valuation upside.Mise à jour du récit • Nov 29
SOLB: Near-Term Outlook Will Hinge On Margin Resilience Amid Industry Pressures
Solvay’s analyst price target was modestly reduced from €27.80 to €27.73. Analysts cite ongoing cautiousness around revenue growth and margin pressures, which are reflected in several recent downward revisions.Mise à jour du récit • Nov 15
SOLB: Future Performance Will Depend On Profit Margin Recovery And Cost Discipline
Solvay's analyst price target was reduced from €28.70 to €27.80, as analysts cited a more cautious outlook on revenue growth and profit margins in recent research updates. Analyst Commentary Analyst sentiment toward Solvay has shifted in recent research updates, with several firms lowering their price targets and highlighting both positive and negative drivers that could influence the company’s near-term performance.Mise à jour du récit • Oct 31
SOLB: Recent Macroeconomic Pressures Will Shape Outlook Amid Stable Fundamentals
Narrative Update on Solvay Solvay’s analyst price target has been lowered slightly, from €28.97 to €28.70, as analysts cite modestly higher discount rates and slightly weaker revenue growth outlooks in their recent updates. Analyst Commentary Recent updates from analysts have provided a nuanced view of Solvay's outlook, highlighting both areas of potential and ongoing challenges that may affect its future performance.Mise à jour du récit • Oct 17
La Rochelle Expansion And Energy Transition Will Secure Future Success
Analysts have modestly reduced their price target for Solvay, lowering it by a small margin in response to recent Street research. The research cites softer profit margins and ongoing revenue pressures, resulting in updated targets between EUR 25.50 and EUR 27.Mise à jour du récit • Oct 03
La Rochelle Expansion And Energy Transition Will Secure Future Success
Solvay's analyst price target has been revised downward by approximately EUR 0.80 per share. Analysts cite ongoing revenue pressure and updated profit margin forecasts to support the adjustment.Mise à jour du récit • Sep 04
La Rochelle Expansion And Energy Transition Will Secure Future Success
Analysts have maintained a cautious outlook on Solvay due to persistent input cost inflation, margin pressure, and weak European demand, resulting in conservative earnings estimates and an unchanged consensus price target of €29.83. Analyst Commentary Cautious sentiment persists due to slower organic growth outlook in core businesses.Article d’analyse • Jan 24
Risks To Shareholder Returns Are Elevated At These Prices For Solvay SA (EBR:SOLB)
It's not a stretch to say that Solvay SA's ( EBR:SOLB ) price-to-sales (or "P/S") ratio of 0.6x right now seems quite...Article d’analyse • Jan 06
Solvay (EBR:SOLB) Will Pay A Dividend Of €0.679
The board of Solvay SA ( EBR:SOLB ) has announced that it will pay a dividend on the 22nd of January, with investors...
Nouveau récit • Dec 25
Green River Expansion And Hydrogen Peroxide Licensing Propel Earnings Growth
Expansion of Green River facility and sustainability efforts position Solvay to benefit from future revenue growth and attract environmentally conscious customers.Article d’analyse • Dec 21
Solvay's (EBR:SOLB) Dividend Will Be €0.679
Solvay SA's ( EBR:SOLB ) investors are due to receive a payment of €0.679 per share on 22nd of January. The dividend...Article d’analyse • Oct 17
Solvay SA (EBR:SOLB) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected
Solvay SA ( EBR:SOLB ) shareholders would be excited to see that the share price has had a great month, posting a 25...Article d’analyse • Sep 18
Are Investors Undervaluing Solvay SA (EBR:SOLB) By 43%?
Key Insights Solvay's estimated fair value is €57.91 based on 2 Stage Free Cash Flow to Equity Solvay is estimated to...Article d’analyse • Aug 28
Solvay SA's (EBR:SOLB) Share Price Could Signal Some Risk
It's not a stretch to say that Solvay SA's ( EBR:SOLB ) price-to-sales (or "P/S") ratio of 0.6x right now seems quite...Article d’analyse • Aug 08
Solvay's (EBR:SOLB) Earnings May Just Be The Starting Point
Solvay SA's ( EBR:SOLB ) earnings announcement last week was disappointing for investors, despite the decent profit...Article d’analyse • Jul 14
Solvay (EBR:SOLB) Has A Somewhat Strained Balance Sheet
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Article d’analyse • Jun 14
Are Investors Undervaluing Solvay SA (EBR:SOLB) By 37%?
Key Insights Using the 2 Stage Free Cash Flow to Equity, Solvay fair value estimate is €50.62 Current share price of...Article d’analyse • May 29
Is It Too Late To Consider Buying Solvay SA (EBR:SOLB)?
While Solvay SA ( EBR:SOLB ) might not have the largest market cap around , it led the ENXTBR gainers with a relatively...Article d’analyse • Apr 24
Solvay SA (EBR:SOLB) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
Solvay SA ( EBR:SOLB ) shareholders have had their patience rewarded with a 26% share price jump in the last month...Article d’analyse • Mar 10
Solvay SA's (EBR:SOLB) Business And Shares Still Trailing The Market
Solvay SA's ( EBR:SOLB ) price-to-earnings (or "P/E") ratio of 2.3x might make it look like a strong buy right now...Article d’analyse • Nov 20
Is Solvay SA (EBR:SOLB) Trading At A 28% Discount?
Key Insights Solvay's estimated fair value is €144 based on 2 Stage Free Cash Flow to Equity Current share price of...Article d’analyse • Nov 06
Solvay (EBR:SOLB) Is Increasing Its Dividend To €1.13
Solvay SA ( EBR:SOLB ) will increase its dividend from last year's comparable payment on the 17th of January to €1.13...Article d’analyse • Nov 02
The Return Trends At Solvay (EBR:SOLB) Look Promising
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other things...Article d’analyse • Oct 19
Here's Why Solvay (EBR:SOLB) Can Manage Its Debt Responsibly
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Rendement pour les actionnaires
| SOLB | BE Chemicals | BE Marché | |
|---|---|---|---|
| 7D | -2.9% | -4.4% | 1.9% |
| 1Y | -8.2% | 7.6% | 25.1% |
Rendement vs Industrie: SOLB a sous-performé le secteur Belgian Chemicals qui a rapporté 7.6 % au cours de l'année écoulée.
Rendement vs marché: SOLB a sous-performé le marché Belgian qui a rapporté 25.1 % au cours de l'année écoulée.
Volatilité des prix
| SOLB volatility | |
|---|---|
| SOLB Average Weekly Movement | 3.6% |
| Chemicals Industry Average Movement | 5.3% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in BE Market | 7.5% |
| 10% least volatile stocks in BE Market | 2.5% |
Cours de l'action stable: SOLB n'a pas connu de volatilité de prix significative au cours des 3 derniers mois par rapport au marché Belgian.
Volatilité au fil du temps: La volatilité hebdomadaire de SOLB ( 4% ) est restée stable au cours de l'année écoulée.
À propos de l'entreprise
| Fondée | Salariés | PDG | Site web |
|---|---|---|---|
| 1863 | 8,400 | Philippe Kehren | www.solvay.com |
Solvay SA fournit des produits chimiques de base et de performance dans le monde entier. La société produit du carbonate de sodium ou du carbonate de soude qui est utilisé dans le verre pour la construction, les panneaux solaires, les conteneurs en verre, les emballages, les batteries lithium-ion pour les véhicules électriques, les détergents et les produits chimiques, ainsi que du bicarbonate de sodium qui est utilisé dans l'alimentation humaine et animale, le traitement des gaz de combustion et les soins de santé. Elle propose également du peroxyde d'hydrogène qui est utilisé pour le blanchiment, la décontamination, la désinfection et l'antisepsie dans des industries telles que la pâte à papier, le textile, l'eau et l'alimentation, ainsi que dans les secteurs des semi-conducteurs, du photovoltaïque, de l'exploitation minière urbaine et des batteries, et qui sert d'intermédiaire pour produire des produits chimiques tels que l'oxyde de propylène et le caprolactame.
Solvay SA Résumé des fondamentaux
| SOLB statistiques fondamentales | |
|---|---|
| Capitalisation boursière | €2.82b |
| Bénéfices(TTM) | -€25.00m |
| Recettes(TTM) | €4.65b |
0.6x
Ratio P/S-112.9x
Ratio P/ELe site SOLB est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
| SOLB compte de résultat (TTM) | |
|---|---|
| Recettes | €4.65b |
| Coût des recettes | €3.63b |
| Marge brute | €1.02b |
| Autres dépenses | €1.04b |
| Les revenus | -€25.00m |
Derniers bénéfices déclarés
Mar 31, 2026
Prochaine date de publication des résultats
Jul 29, 2026
| Résultat par action (EPS) | -0.24 |
| Marge brute | 21.89% |
| Marge bénéficiaire nette | -0.54% |
| Ratio dettes/capitaux propres | 185.9% |
Quelles ont été les performances à long terme de SOLB?
Voir les performances historiques et les comparaisonsDividendes
9.0%
Rendement actuel des dividendes-1,016%
Ratio de distributionAnalyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/06/25 08:42 |
| Cours de l'action en fin de journée | 2026/06/25 00:00 |
| Les revenus | 2026/03/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d'analyse utilisé pour générer ce rapport sont disponibles sur notre page Github, nous proposons également des guides pour apprendre à utiliser nos rapports et des tutoriels sur YouTube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Solvay SA est couverte par 37 analystes. 10 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Katie Richards | Barclays |
| James Stewart | Barclays |
| Andreas Heine | Barclays |